Advertisement
U.S. markets close in 6 hours 24 minutes

Oncternal Therapeutics, Inc. (ONCT)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Visitors trend2W10W9M
0.8000-0.3400 (-29.94%)
As of 09:36AM EST. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 3.37M
Enterprise Value -11.01M
Trailing P/E 2.11
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.37
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-84.17%
S&P500 52-Week Change 331.18%
52 Week High 313.2000
52 Week Low 30.7600
50-Day Moving Average 31.3740
200-Day Moving Average 36.0423

Share Statistics

Avg Vol (3 month) 397.96k
Avg Vol (10 day) 367.35k
Shares Outstanding 52.96M
Implied Shares Outstanding 63.15M
Float 82.71M
% Held by Insiders 19.23%
% Held by Institutions 112.07%
Shares Short (Oct 31, 2024) 445.35k
Short Ratio (Oct 31, 2024) 40.36
Short % of Float (Oct 31, 2024) 41.59%
Short % of Shares Outstanding (Oct 31, 2024) 41.53%
Shares Short (prior month Sep 30, 2024) 417.89k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Jan 08, 2024

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Sep 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,757.29%

Management Effectiveness

Return on Assets (ttm)-76.45%
Return on Equity (ttm)-149.86%

Income Statement

Revenue (ttm)2.16M
Revenue Per Share (ttm)0.73
Quarterly Revenue Growth (yoy)176.00%
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-34.58M
Diluted EPS (ttm)-11.6900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.58M
Total Cash Per Share (mrq)4.93
Total Debt (mrq)191k
Total Debt/Equity (mrq)2.09%
Current Ratio (mrq)2.39
Book Value Per Share (mrq)3.09

Cash Flow Statement

Operating Cash Flow (ttm)-26.63M
Levered Free Cash Flow (ttm)-17.68M